HIM
SEM

Hillsdale Investment Management’s Select Medical SEM Stock Holding History

Hillsdale Investment Management’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-334
Closed -$6.28K – 672
2024
Q3 		$6.28K Hold
334
– – ﹤0.01% 563
2024
Q2 		$6.31K Buy
+334
New +$5.7K ﹤0.01% 527
2022
Q1 		– Sell
-255,942
Closed -$4.05M – 610
2021
Q4 		$4.05M Sell
255,942
-59,207
-19% -$1.01M 0.27% 126
2021
Q3 		$6.14M Hold
315,149
– – 0.47% 45
2021
Q2 		$7.18M Sell
315,149
-16,889
-5% -$350K 0.57% 31
2021
Q1 		$6.1M Buy
332,038
+3,712
+1% +$60.9K 0.51% 47
2020
Q4 		$4.89M Buy
328,326
+70,342
+27% +$918K 0.47% 51
2020
Q3 		$2.89M Sell
257,984
-79,994
-24% -$788K 0.28% 111
2020
Q2 		$2.68M Hold
337,978
– – 0.24% 127
2020
Q1 		$2.73M Sell
337,978
-1,856
-0.5% -$22.1K 0.33% 85
2019
Q4 		$4.27M Buy
339,834
+115,629
+52% +$1.25M 0.37% 90
2019
Q3 		$2M Buy
224,205
+33,408
+18% +$292K 0.18% 150
2019
Q2 		$1.63M Hold
190,797
– – 0.16% 146
2019
Q1 		$1.45M Sell
190,797
-50,112
-21% -$403K 0.13% 145
2018
Q4 		$1.99M Buy
240,909
+98,368
+69% +$941K 0.24% 91
2018
Q3 		$1.41M Hold
142,541
– – 0.19% 127
2018
Q2 		$1.39M Buy
142,541
+9,280
+7% +$91.1K 0.17% 128
2018
Q1 		$1.24M Hold
133,261
– – 0.17% 126
2017
Q4 		$1.27M Buy
133,261
+29,696
+29% +$284K 0.2% 120
2017
Q3 		$1.07M Buy
+103,565
New +$956K 0.18% 130
2014
Q4 		– Sell
-80,365
Closed -$521K – 586
2014
Q3 		$521K Hold
80,365
– – 0.17% 92
2014
Q2 		$675K Buy
80,365
+41,389
+106% +$321K 0.15% 78
2014
Q1 		$261K Buy
+38,976
New +$236K 0.07% 238

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Hillsdale Investment Management's SEM Position: Q4 2024 in Review

Hillsdale Investment Management sold out of Select Medical (SEM) in Q4 2024, closing a stake of 334 shares — an estimated $6.28K sold.

Hillsdale Investment Management first reported a position in SEM in Q1 2014 and held it in 23 quarters. The position peaked at $7.18M in Q2 2021. 271 funds tracked by Wall St. Rank hold SEM as of Q4 2024.

  • Hillsdale Investment Management reported no remaining Select Medical position as of Q4 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 334 Select Medical shares in Q4 2024, an estimated $6.28K.
  • Hillsdale Investment Management first reported a position in Select Medical in Q1 2014 and held it in 23 quarters.
  • Hillsdale Investment Management's Select Medical position peaked at $7.18M in Q2 2021.
  • 271 funds tracked by Wall St. Rank held Select Medical as of Q4 2024.

Based on Hillsdale Investment Management's 13F filing for Q4 2024, filed 11 Feb 2025.